FDA Inspection 1079760 — Eversight
The FDA completed an inspection of Eversight on Feb 19, 2019 in Clark, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 19, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Clark, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12230 | 21 CFR 1271.50(a) | Responsible person to determine, document |
| 12236 | 21 CFR 1271.55(a)(2) | Eligibility statement--basis of determination |